PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6904
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol ; volume:2 ; number:1 ; day:15 ; month:8 ; year:2002 ; pages:1-21 ; date:12.2002
BMC clinical pharmacology ; 2, Heft 1 (15.8.2002), 1-21, 12.2002
- Urheber
-
Levitt, David G.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1472-6904-2-5
- URN
-
urn:nbn:de:1111-2016072029782
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Levitt, David G.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Interspecies extrapolation by physiologically based pharmacokinetic modeling
Human physiologically based pharmacokinetic model for propofol
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Ocular Physiologically Based Pharmacokinetic Modeling for Ointment Formulations
Application of population, physiologically based, and semi-physiological pharmacokinetic modeling to assess sources of pharmacokinetic variability in individual drugs
A Physiologically Based Pharmacokinetic Model of Isoniazid and Its Application in Individualizing Tuberculosis Chemotherapy
Adapting physiologically-based pharmacokinetic models for machine learning applications
Highlight report: Interspecies extrapolation by physiologically based pharmacokinetic modeling
Physiologically based pharmacokinetic modeling of intravenously administered nanoformulated substances
Estimation of feasible solution space using Cluster Newton Method: application to pharmacokinetic analysis of irinotecan with physiologically-based pharmacokinetic models
Physiologically based pharmacokinetic modeling of arterial – antecubital vein concentration difference